Macular thickness varies with age-related macular degeneration genetic risk variants in the UK Biobank cohort
Abstract To evaluate the influence AMD risk genomic variants have on macular thickness in the normal population. UK Biobank participants with no significant ocular history were included using the UK Biobank Resource (project 2112). Spectral-domain optical coherence tomography (SD-OCT) images were ta...
Saved in:
Main Authors: | Rebecca A. Kaye, Karina Patasova, Praveen J. Patel, Pirro Hysi, Andrew J. Lotery, The UK Biobank Eye and Vision Consortium |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/37ff147fecd04efb94f0bab3b28719e3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gene, Cell and Antibody-Based Therapies for the Treatment of Age-Related Macular Degeneration
by: Akyol E, et al.
Published: (2020) -
A retrospective study of the real-life utilization and effectiveness of ranibizumab therapy for neovascular age-related macular degeneration in the UK
by: Hykin P, et al.
Published: (2016) -
Full-thickness macular hole formation following anti-VEGF injections for neovascular age-related macular degeneration
by: Kabanarou SA, et al.
Published: (2017) -
Pegaptanib sodium for neovascular age-related macular degeneration: clinical experience in the UK
by: Sobha Sivaprasad, et al.
Published: (2008) -
Genetic variation affects morphological retinal phenotypes extracted from UK Biobank optical coherence tomography images.
by: Hannah Currant, et al.
Published: (2021)